Capricor Therapeutics | CAPR - Sales Revenues


Capricor Therapeutics reported $0 in Sales Revenues for its fiscal quarter ending in March of 2025.





Sales Change Date
Alterity Therapeutics Limited AUD 11.38K 10.23K Dec/2022
Bioline Rx USD 427K 123K Sep/2025
Capricor Therapeutics USD 0 11.13M Mar/2025
Cipla INR 75.18B 710M Dec/2025
Cytokinetics USD 17.76M 15.83M Dec/2025
Geron USD 48.02M 820K Dec/2025
Grifols EUR 2.34B 159.69M Mar/2026
J&J USD 24.6B 610M Dec/2025
Plus Therapeutics USD 1.31M 73K Dec/2023
Prothena USD 2.42M 2M Sep/2025
PTC Therapeutics USD 164.7M 46.3M Dec/2025
Sarepta Therapeutics USD 442.9M 43.5M Dec/2025